Irvington-NY based Electro-Optical Sciences (EOS), developer of The MelaFind System, a handheld imaging device that detects melanomas at an early stage, announced last week that its pivotal trial sites have closed: all […]
OneMedForum 2009: Panels and Speakers
The OneMedPlace finance conference for emerging med tech companies, the OneMedForum, will be held January 13-14 in San Francisco. Click here to learn more. Our featured panelists and speakers will be recognized […]
Mike Landess’ Battle with Prostate Cancer
A quick shout to Mike Landess, a Denver, CO newsman who this week released a half hour DVD special on prostate cancer (check out his blog). Mike was diagnosed with the disease […]
[Video Profile] Interview with Michael Fons, VP Corporate Development at Inovio Biomedical
Inovio Biomedical’s electroporation technology uses brief, controlled electrical pulses to increase cellular uptake of gene expression in DNA-based treatments; this enhances the potency of DNA-based immunotherapies against cancers and infectious diseases. Inovio […]
Trod Medical: FDA 510(k) Clearance for Encage
Trod Medical has received FDA 510(k) clearance for Encage, a minimally invasive technology for soft tissue ablation. The surgical system allows for precise percutaneous ablation of target tissue with well-defined margins, helping […]
Endocare and Galil Medical to Merge
Only months after Healthtronics withdrew its offer to acquire Endocare for $2.28 per share, Endocare and privately held Galil Medical have agreed to merge. The combined company will be focused on the […]
[Video Interview] Richard Taney, President & CEO of Delcath Systems
One of the central problems in using chemotherapy to treat cancer is its harmful effect on organ health. Lower dosages of the drug are often used to limit side effects, which may […]
Clarient: Q3 Revenues up 59%; Raises Guidance
Third quarter revenues at Clarient increased 59% to $19.0 million from the $11.9 million reported in Q3 2007. This marks the company’s 17th consecutive quarter of sequential revenue growth. Higher testing volume, […]
